Identification of basophilic cells that express mast cell granule proteases in the peripheral blood of asthma, allergy, and drug-reactive patients.
Metachromatic cells in the peripheral blood of patients with asthma, allergy, or an allergic drug reaction were evaluated for their nuclear morphology, surface expression of the mast cell (MC) marker c-kit, surface expression of the basophil marker Bsp-1, and granule expression of MC proteases. Consistent with previous findings by others, Bsp-1+/metachromatic cells represented <1% of the cells in the peripheral blood of normal individuals. These cells generally contained segmented nuclei. Very little, if any, tryptase (Try), chymase (Chy), or carboxypeptidase A (CPA) was found in their granules, and very little, if any, c-kit was observed on their surfaces. The number of metachromatic cells increased in the peripheral blood of the three groups of patients. Like the basophils in normal individuals, most of these metachromatic cells contained segmented nuclei and expressed Bsp-1. However, in contrast to the basophils in normal individuals, many of the metachromatic cells in the three patient groups expressed c-kit, Try, Chy, and/or CPA. That the metachromatic cells in the blood of our patients have some features of MCs and some features of basophils suggests that human basophils and MCs are derived from a common progenitor. As assessed by the chloroacetate esterase cytochemical assay, the immunoreactive Chy in the peripheral blood of these patients is enzymatically active. Because MC proteases regulate numerous immunologic and other biologic systems, the expression of Try, Chy, and/or CPA in a peripheral blood-localized cell in an individual having asthma, allergy, or an allergic drug reaction has important clinical implications.
Li
L
L
Department of Medicine, University of New South Wales, Australia.
Li
Y
Y
Reddel
S W
SW
Cherrian
M
M
Friend
D S
DS
Stevens
R L
RL
Krilis
S A
SA
D000208:Acute Disease; D000328:Adult; D001249:Asthma / Q000097:blood*; D001491:Basophils / Q000201:enzymology*; D015415:Biomarkers; D002268:Carboxypeptidases / Q000097:blood*; D043422:Carboxypeptidases A; D053818:Chymases; D003289:Convalescence; D004342:Drug Hypersensitivity / Q000097:blood*; D004790:Enzyme Induction; D005260:Female; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000097:blood*; D017403:In Situ Hybridization; D007527:Isoenzymes / Q000097:blood*; D007958:Leukocyte Count; D008297:Male; D008407:Mast Cells / Q000201:enzymology*; D008875:Middle Aged; D012697:Serine Endopeptidases / Q000097:blood*; D013194:Staining and Labeling; D053802:Tryptases
D015415:Biomarkers; D007527:Isoenzymes; D002268:Carboxypeptidases; D043422:Carboxypeptidases A; D012697:Serine Endopeptidases; C083294:chymase 2; D053818:Chymases; D053802:Tryptases